ID   FGE_THECD               Reviewed;         303 AA.
AC   D1A7C3;
DT   20-JUN-2018, integrated into UniProtKB/Swiss-Prot.
DT   19-JAN-2010, sequence version 1.
DT   07-APR-2021, entry version 58.
DE   RecName: Full=Formylglycine-generating enzyme {ECO:0000303|PubMed:26403223, ECO:0000303|PubMed:27862795};
DE            Short=FGE {ECO:0000303|PubMed:26403223, ECO:0000303|PubMed:27862795};
DE            EC=1.8.3.7 {ECO:0000269|PubMed:26403223, ECO:0000269|PubMed:27862795};
GN   OrderedLocusNames=Tcur_4811 {ECO:0000312|EMBL:ACZ00329.1};
OS   Thermomonospora curvata (strain ATCC 19995 / DSM 43183 / JCM 3096 / NBRC
OS   15933 / NCIMB 10081 / Henssen B9).
OC   Bacteria; Actinobacteria; Streptosporangiales; Thermomonosporaceae;
OC   Thermomonospora.
OX   NCBI_TaxID=471852;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 19995 / DSM 43183 / JCM 3096 / NBRC 15933 / NCIMB 10081 /
RC   Henssen B9;
RX   PubMed=21475583; DOI=10.4056/sigs.1453580;
RA   Chertkov O., Sikorski J., Nolan M., Lapidus A., Lucas S., Del Rio T.G.,
RA   Tice H., Cheng J.F., Goodwin L., Pitluck S., Liolios K., Ivanova N.,
RA   Mavromatis K., Mikhailova N., Ovchinnikova G., Pati A., Chen A.,
RA   Palaniappan K., Djao O.D., Land M., Hauser L., Chang Y.J., Jeffries C.D.,
RA   Brettin T., Han C., Detter J.C., Rohde M., Goeker M., Woyke T., Bristow J.,
RA   Eisen J.A., Markowitz V., Hugenholtz P., Klenk H.P., Kyrpides N.C.;
RT   "Complete genome sequence of Thermomonospora curvata type strain (B9).";
RL   Stand. Genomic Sci. 1:13-22(2011).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF CYS-187; CYS-231; CYS-284 AND CYS-298.
RX   PubMed=26403223; DOI=10.1002/cbic.201500322;
RA   Knop M., Engi P., Lemnaru R., Seebeck F.P.;
RT   "In vitro reconstitution of formylglycine-generating enzymes requires
RT   copper(I).";
RL   ChemBioChem 16:2147-2150(2015).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF CYS-187; CYS-231; CYS-269; CYS-274; CYS-284 AND CYS-298.
RX   PubMed=27862795; DOI=10.1002/cbic.201600359;
RA   Knop M., Dang T.Q., Jeschke G., Seebeck F.P.;
RT   "Copper is a cofactor of the formylglycine-generating enzyme.";
RL   ChemBioChem 18:161-165(2017).
RN   [4] {ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY}
RP   X-RAY CRYSTALLOGRAPHY (1.28 ANGSTROMS) OF 20-303 IN COMPLEX WITH CALCIUM
RP   AND SILVER, COPPER-BINDING SITES, AND REACTION MECHANISM.
RX   PubMed=28544744; DOI=10.1002/anie.201702901;
RA   Meury M., Knop M., Seebeck F.P.;
RT   "Structural basis for copper-oxygen mediated C-H bond activation by the
RT   formylglycine-generating enzyme.";
RL   Angew. Chem. Int. Ed. Engl. 56:8115-8119(2017).
CC   -!- FUNCTION: Oxidase that catalyzes the conversion of cysteine to 3-
CC       oxoalanine on target proteins. 3-oxoalanine modification, which is also
CC       named formylglycine (fGly), occurs in the maturation of arylsulfatases
CC       and some alkaline phosphatases that use the hydrated form of 3-
CC       oxoalanine as a catalytic nucleophile. {ECO:0000269|PubMed:26403223,
CC       ECO:0000269|PubMed:27862795}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 a thiol + L-cysteinyl-[sulfatase] + O2 = 3-oxo-L-alanyl-
CC         [sulfatase] + an organic disulfide + H(+) + H2O + hydrogen sulfide;
CC         Xref=Rhea:RHEA:51152, Rhea:RHEA-COMP:12900, Rhea:RHEA-COMP:12901,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29256, ChEBI:CHEBI:29919, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:35489, ChEBI:CHEBI:85621; EC=1.8.3.7;
CC         Evidence={ECO:0000269|PubMed:26403223, ECO:0000269|PubMed:27862795};
CC   -!- COFACTOR:
CC       Name=Cu(+); Xref=ChEBI:CHEBI:49552;
CC         Evidence={ECO:0000269|PubMed:26403223, ECO:0000269|PubMed:27862795,
CC         ECO:0000269|PubMed:28544744};
CC       Note=The catalytic copper is required to activate oxygen and catalyze
CC       oxidative C-H activation. {ECO:0000269|PubMed:28544744};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=580 uM for [sulfatase]-L-cysteine (in presence of Cu(+))
CC         {ECO:0000269|PubMed:27862795};
CC         Note=Kcat is 1.6 min(-1) in presence of Cu(+).
CC         {ECO:0000269|PubMed:26403223, ECO:0000269|PubMed:27862795};
CC   -!- PATHWAY: Protein modification; sulfatase oxidation.
CC       {ECO:0000269|PubMed:26403223, ECO:0000269|PubMed:27862795}.
CC   -!- SIMILARITY: Belongs to the sulfatase-modifying factor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001738; ACZ00329.1; -; Genomic_DNA.
DR   PDB; 5NXL; X-ray; 1.66 A; A=20-303.
DR   PDB; 5NYY; X-ray; 1.28 A; A=20-303.
DR   PDB; 6S07; X-ray; 1.04 A; A=1-302.
DR   PDBsum; 5NXL; -.
DR   PDBsum; 5NYY; -.
DR   PDBsum; 6S07; -.
DR   SMR; D1A7C3; -.
DR   STRING; 471852.Tcur_4811; -.
DR   EnsemblBacteria; ACZ00329; ACZ00329; Tcur_4811.
DR   KEGG; tcu:Tcur_4811; -.
DR   eggNOG; COG1262; Bacteria.
DR   HOGENOM; CLU_012431_4_2_11; -.
DR   OMA; YEWTADC; -.
DR   UniPathway; UPA00910; -.
DR   Proteomes; UP000001918; Chromosome.
DR   GO; GO:1903136; F:cuprous ion binding; IDA:UniProtKB.
DR   GO; GO:0120147; F:Formylglycine-generating oxidase activity; IDA:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; IDA:UniProtKB.
DR   GO; GO:0018158; P:protein oxidation; IDA:UniProtKB.
DR   Gene3D; 3.90.1580.10; -; 1.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR005532; SUMF_dom.
DR   InterPro; IPR042095; SUMF_sf.
DR   Pfam; PF03781; FGE-sulfatase; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Copper; Metal-binding; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..303
FT                   /note="Formylglycine-generating enzyme"
FT                   /id="PRO_0000444618"
FT   METAL           188
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           189
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           202
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           204
FT                   /note="Calcium 1; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           222
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           223
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           225
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           227
FT                   /note="Calcium 2; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:28544744,
FT                   ECO:0007744|PDB:5NXL, ECO:0007744|PDB:5NYY"
FT   METAL           269
FT                   /note="Copper(1+); catalytic"
FT                   /evidence="ECO:0000269|PubMed:27862795,
FT                   ECO:0000269|PubMed:28544744, ECO:0007744|PDB:5NXL,
FT                   ECO:0007744|PDB:5NYY"
FT   METAL           274
FT                   /note="Copper(1+); catalytic"
FT                   /evidence="ECO:0000269|PubMed:27862795,
FT                   ECO:0000269|PubMed:28544744, ECO:0007744|PDB:5NXL,
FT                   ECO:0007744|PDB:5NYY"
FT   MUTAGEN         187
FT                   /note="C->A: In 4C; increased formylglycine-generating
FT                   enzyme activity; when associated with A-231; A-284 and A-
FT                   298."
FT                   /evidence="ECO:0000269|PubMed:26403223,
FT                   ECO:0000269|PubMed:27862795"
FT   MUTAGEN         231
FT                   /note="C->A: In 4C; increased formylglycine-generating
FT                   enzyme activity; when associated with A-187; A-284 and A-
FT                   298."
FT                   /evidence="ECO:0000269|PubMed:26403223,
FT                   ECO:0000269|PubMed:27862795"
FT   MUTAGEN         269
FT                   /note="C->S: Abolished formylglycine-generating enzyme
FT                   activity and ability to bind Cu(+)."
FT                   /evidence="ECO:0000269|PubMed:27862795"
FT   MUTAGEN         274
FT                   /note="C->S: Abolished formylglycine-generating enzyme
FT                   activity and ability to bind Cu(+)."
FT                   /evidence="ECO:0000269|PubMed:27862795"
FT   MUTAGEN         284
FT                   /note="C->A: In 4C; increased formylglycine-generating
FT                   enzyme activity; when associated with A-187; A-231 and A-
FT                   298."
FT                   /evidence="ECO:0000269|PubMed:26403223,
FT                   ECO:0000269|PubMed:27862795"
FT   MUTAGEN         298
FT                   /note="C->A: In 4C; increased formylglycine-generating
FT                   enzyme activity; when associated with A-187; A-231 and A-
FT                   284."
FT                   /evidence="ECO:0000269|PubMed:26403223,
FT                   ECO:0000269|PubMed:27862795"
FT   HELIX           13..17
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          20..23
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          25..31
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           39..41
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          47..51
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          54..59
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           63..73
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           78..82
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          84..88
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           89..91
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          109..113
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           140..149
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           157..165
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           181..183
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   TURN            194..196
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          223..234
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           239..241
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   HELIX           245..248
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          258..264
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   TURN            271..274
FT                   /evidence="ECO:0007744|PDB:6S07"
FT   STRAND          283..285
FT                   /evidence="ECO:0007744|PDB:6S07"
SQ   SEQUENCE   303 AA;  33276 MW;  FFAF53CCC62F82DA CRC64;
     MPSFDFDIPR RSPQEIAKGM VAIPGGTFRM GGEDPDAFPE DGEGPVRTVR LSPFLIDRYA
     VSNRQFAAFV KATGYVTDAE RYGWSFVFHA HVAPGTPVMD AVVPEAPWWV AVPGAYWKAP
     EGPGSSITDR PNHPVVHVSW NDAVAYATWA GKRLPTEAEW EMAARGGLDQ ARYPWGNELT
     PRGRHRCNIW QGTFPVHDTG EDGYTGTAPV NAFAPNGYGL YNVAGNVWEW CADWWSADWH
     ATESPATRID PRGPETGTAR VTKGGSFLCH ESYCNRYRVA ARTCNTPDSS AAHTGFRCAA
     DPL
//
